11/01/2017 21:22:00

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Seattle Genetics, Inc. To Contact The Firm Before Lead Plaintiff Deadline

NEW YORK, Jan. 11, 2017 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Seattle Genetics, Inc. (“Seattle Genetics” or the “Company”) (NASDAQ:SGEN) of the March 13, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.

The lawsuit has been filed in the U.S. District Court for the Western District of Washington on behalf of all those who purchased Seattle Genetics securities between October 27, 2016 and December 23, 2016 (the “Class Period”).  The case, Patel v. Seattle Genetics, Inc. et al, No. 2:17-cv-00041 was filed on January 10, 2017.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) the Company’s experimental cancer drug, vadastuximab talirine, presents a significant risk of fatal hepatotoxicity; (ii) Seattle Genetics had overstated the viability of vadastuximab talirine as an acute myeloid leukemia treatment; and (iii) as a result, Seattle Genetics’ public statements were materially false and misleading.

Specifically, on December 27, 2016, Seattle Genetics announced that the U.S. Food and Drug Administration had placed a clinical hold or partial clinical hold on several early stage trials of vadastuximab talirine, to evaluate the potential risk of hepatotoxicity.  The Company stated, in part, that “six patients have been identified with hepatotoxicity, including several cases of veno-occlusive disease, with four fatal events.”

After the announcement, Seattle Genetics’ share price fell from $61.86 per share on December 23, 2016 to a closing price of $52.36 on December 27, 2016—a $9.50 or a 15.36% drop.

Request more information now by clicking here: www.faruqilaw.com/SGEN. There is no cost or obligation to you.

Take Action

If you invested in Seattle Genetics stock or options between October 27, 2016 and December 23, 2016 and would like to discuss your legal rights, visit www.faruqilaw.com/SGEN. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Seattle Genetics’ conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class that is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. 

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP

685 Third Avenue, 26th Floor

New York, NY 10017

Attn: Richard Gonnello, Esq.

rgonnello@faruqilaw.com

Telephone: (877) 247-4292 or (212) 983-9330

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
27 May
PNDORA
Normal 0 21 false false false DA X-NONE X-NONE ..
46
23 May
 
For nogle af mine kunder, laver jeg en kvartals-analyse over, hvordan de Nordiske selskabers indtjen..
25
28 May
PNDORA
Alle disse Pandora tråde vidner i høj grad om desperation.
24
27 May
PNDORA
Jeg læser i indlæggene om Pandora, da jeg selv er investeret i den aktie, og specielt i tråd nr. 390..
14
25 May
PNDORA
Tjah det er altid svaert for en amatoer som mig at vide hvornaar er det rigtige tidspunkt at koebe e..
14
24 May
PNDORA
Nej for det er Breaking news.
12
23 May
 
Man korser sig når man ser hvad nogle mennesker kan finde på og skrive, blot fordi de kan gøre det a..
12
23 May
 
Hold øje med at politikere og andre nu som sædvanligt vil mane os til "at stå sammen" og "ikke lade ..
12
25 May
ZEAL
-Jeg mindes ikke at handlet med en aktie som deler vandene så meget som Zealand Pharma. Jeg har vær..
11
23 May
 
Hellere en nytteløs klovn end en svinsk og ubehagelig klovn som dig. Mage til ubehagelig optræden.
11

Form 8.3 - AXA INVESTMENT MANAGERS : Berendsen Plc

29/05/2017 14:25:13
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: AXA Investment Managers (b) Owner o..

Astana International Financial Centre JSC and Nasdaq Sign Technology Deal for New AIFC Exchange

29/05/2017 08:00:13
The  AIFC Exchange  will run on Nasdaq Financial Framework trading technology  The new exchange is targeted to launch in late-2017 NEW YORK & ASTANA, Kazakhstan, May 29, 2017 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq:NDAQ) and Astana International Financial Centre JSC (AIFC) today announced a new, significant agreement. Nasda..

P. Schoenfeld Asset Management LLP : Form 8.3 - Booker Group plc

26/05/2017 15:00:03
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: P. Schoenfeld Asset Management LLP (b) Owner or..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
ANNOUNCEMENT OF A CHANGE IN SHAREHOLDING ACCORDING TO CHAPTER 9, SECTION 10 OF THE FINNISH SECURITIES MARKET ACT
2
ABcann Global and Cannabis Wheaton Sign Interim Agreement for Construction of Additional Cannabis Cultivation Facility
3
German Appeals Court overrules District Court on infringement of SSH patent by Sony but grants a stay pending validity review
4
SAG GEST - SOLUÇÕES AUTOMÓVEL GLOBAIS, SGPS, SA - Consolidated Report Three Months Ended 31 March 2017
5
Astana International Financial Centre JSC and Nasdaq Sign Technology Deal for New AIFC Exchange

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
30 May 2017 06:22:37
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170517.1 - EUROWEB4 - 2017-05-30 07:22:37 - 2017-05-30 06:22:37 - 1000 - Website: OKAY